VIGORITA, Maria
 Distribuzione geografica
Continente #
EU - Europa 3.019
NA - Nord America 2.938
AS - Asia 1.447
SA - Sud America 486
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 2
Totale 7.950
Nazione #
US - Stati Uniti d'America 2.886
RU - Federazione Russa 1.501
SG - Singapore 609
CN - Cina 460
BR - Brasile 416
IE - Irlanda 401
SE - Svezia 391
UA - Ucraina 198
DE - Germania 163
HK - Hong Kong 143
FI - Finlandia 77
FR - Francia 75
GB - Regno Unito 70
IT - Italia 70
IN - India 55
VN - Vietnam 51
AR - Argentina 23
CA - Canada 23
PL - Polonia 16
UZ - Uzbekistan 15
MX - Messico 14
CO - Colombia 13
ZA - Sudafrica 13
BD - Bangladesh 12
IQ - Iraq 12
IR - Iran 12
ES - Italia 10
TR - Turchia 10
BE - Belgio 8
ID - Indonesia 8
MA - Marocco 8
EC - Ecuador 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
JO - Giordania 6
JP - Giappone 6
PK - Pakistan 6
PY - Paraguay 6
CL - Cile 5
GR - Grecia 5
MY - Malesia 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
PT - Portogallo 4
RS - Serbia 4
SA - Arabia Saudita 4
BO - Bolivia 3
CR - Costa Rica 3
GT - Guatemala 3
JM - Giamaica 3
LB - Libano 3
NL - Olanda 3
NO - Norvegia 3
OM - Oman 3
UY - Uruguay 3
AL - Albania 2
AT - Austria 2
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
IL - Israele 2
LT - Lituania 2
NG - Nigeria 2
PE - Perù 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
NI - Nicaragua 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 7.930
Città #
Moscow 443
Dublin 400
Jacksonville 352
Ashburn 341
Dallas 335
Singapore 328
Chandler 275
Nyköping 265
Dearborn 188
Beijing 167
Hong Kong 143
San Jose 131
Council Bluffs 104
The Dalles 79
Cambridge 62
Medford 61
Princeton 61
Los Angeles 57
Lauterbourg 52
Ann Arbor 45
Boardman 40
Des Moines 37
Buffalo 34
São Paulo 33
New York 30
Munich 28
Jinan 26
Ho Chi Minh City 25
Tianjin 23
Lancaster 21
San Mateo 21
Columbus 16
Phoenix 15
Guangzhou 14
Warsaw 14
Chennai 13
Santa Clara 13
Tashkent 13
Belo Horizonte 12
Haikou 12
Montreal 12
Rio de Janeiro 12
Turku 12
Woodbridge 12
Frankfurt am Main 11
Ardabil 10
Brasília 10
Hanoi 10
Shenyang 10
Wilmington 10
Houston 9
Nanchang 9
Orem 9
Brussels 8
Johannesburg 8
Nanjing 8
Stockholm 8
Atlanta 7
Denver 7
Milan 7
San Francisco 7
Seattle 7
Bremen 6
Changsha 6
Contagem 6
Curitiba 6
Guarulhos 6
Hebei 6
London 6
Redondo Beach 6
Turin 6
Amman 5
Asunción 5
Baghdad 5
Boston 5
Brno 5
Campinas 5
Dhaka 5
Fuzhou 5
Goiânia 5
Hangzhou 5
Monmouth Junction 5
Ningbo 5
Pune 5
Shanghai 5
Sorocaba 5
Taiyuan 5
Taizhou 5
Tokyo 5
Washington 5
Zhengzhou 5
Augusta 4
Bogotá 4
Brooklyn 4
Charlotte 4
Helsinki 4
Indore 4
Istanbul 4
Louisville 4
Mumbai 4
Totale 4.722
Nome #
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 253
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 210
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 191
9-fluorenon-4-carboxamides: synthesis, conformational analysis, anti-HSV-2, and immunomodulatory evaluation. Note II 189
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 185
FLUOROCONTAINING D-CYCLOSERINES - SYNTHESIS AND INVITRO EVALUATION OF ANTIMICROBIAL AND ANTIVIRAL ACTIVITIES 179
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 178
4-Carbossiamido-9-fluorenoni: proprietà anti-HSV-2 e immunostimolanti 177
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 176
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 173
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 171
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 166
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 163
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 163
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 162
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 160
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 159
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 159
Biocatalysed synthesis of beta-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties 158
Design and synthesis of DNA-intercalating 9-fluoren-beta-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents 152
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 150
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 149
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 147
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 139
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 133
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 126
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 126
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 125
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 122
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 121
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 119
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 119
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 117
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 111
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 111
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 110
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 109
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 107
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 106
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 106
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 105
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 105
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 103
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 103
Halogenated isoniazid derivatives .6. Evaluation of anti-HSV-1 and anti-HIV-1 in vitro activities of fluorinated analogues 102
Nuclear magnetic resonance of psychotherapeutic agents. IV. Conformational analysis of 2,3-dihydro.1H-1,4-benzodiazepines 101
In vitro Antimycobacterial Activity of Isoniazid-related Metalchelates 100
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 100
Tetraplex DNA specific ligand based on the fluorenone-carboxamide scaffold. 99
Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI. 98
Nuclear magnetic resonance of 1,4-benzodiazepines. II. Stereochemistry of 1,3-dihydro-2H-1,4-benzodiazepin-2-ones by lanthanide shift reagents 98
Nuclear magnetic resonance spectra of psychotherapeutic agents. V. Conformational analysis of 1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-ones 96
Sintesi, attività in vitro e SARs di 2,4-tiazolidindioni inibitori dell'aldoso reduttasi 93
Risonanza magnetica nucleare di 1,4-benzodiazepine. Accoppiamento attraverso lo spazio di 2,3-diidro-1H-1,4-benzodiazepine 1-sostituite 92
Isonicotinoilidrazoni fluorurati: reattività ed attività antimicobatterica ed anti-HIV 91
Isonicotinoilidrazoni: reattività con diazometano ed attività antimicobatterica ed anti-HIV 88
In Vitro Aldose Reductase Inhibitory Activity of 5-Benzyl-2,4-thiazolidinediones 86
Metal(II) complexes with isoniazid analogues: synthesis and pharmacological activity 82
Reattività di isonicotinoilidrazoni con diazometano 79
Metalchelati di aroilidrazoni. Sintesi e valutazione dell'attività antitubercolare 76
Nuclear magnetic resonance spectra of psychotherapeutic agents. III. Stereochemistry of 1-methyl5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-2,4-diones 76
Totale 7.950
Categoria #
all - tutte 26.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.343


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022407 0 94 3 10 22 0 27 14 6 27 70 134
2022/20231.161 94 130 57 100 76 118 27 57 476 9 17 0
2023/2024204 16 34 32 13 24 42 1 13 0 3 0 26
2024/20251.093 13 9 19 79 42 33 42 212 297 65 107 175
2025/20263.550 180 318 296 241 241 788 438 417 403 128 64 36
2026/2027149 47 102 0 0 0 0 0 0 0 0 0 0
Totale 7.950